STOCK TITAN

Pyxis Oncology: OrbiMed firms report 7% ownership

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Pyxis Oncology, Inc. (PYXS) was the subject of Schedule 13G reports in which OrbiMed Advisors LLC reported beneficial ownership of 4,013,720 shares (3.4%), with shared voting and dispositive power, and OrbiMed Capital LLC reported 4,348,197 shares (3.6%), with sole voting and dispositive power.

The two reporting persons stated that they hold 7.0% of the common stock on behalf of other persons entitled to receive dividends or sale proceeds.

Beneficial ownership, OrbiMed Advisors LLC 4,013,720 shares 3.4% of the class
Beneficial ownership, OrbiMed Capital LLC 4,348,197 shares 3.6% of the class
Shares held on behalf of other persons 7.0% of the common stock Other persons have rights to dividends or proceeds from sales of these securities
beneficial ownership regulatory
"Amount beneficially owned: OrbiMed Advisors LLC"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
dispositive power regulatory
"Shared dispositive power 4,013,720"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many PYXS shares did OrbiMed Advisors and OrbiMed Capital report?

OrbiMed Advisors LLC reported beneficial ownership of 4,013,720 shares, or 3.4%, and OrbiMed Capital LLC reported 4,348,197 shares, or 3.6%.

Who exercises voting and investment power over the reported PYXS shares?

OrbiMed Advisors LLC and OrbiMed Capital LLC exercise voting and investment power through a management committee comprising Carl L. Gordon, W. Carter Neild and Geoffrey C. Hsu. Each committee member disclaims beneficial ownership of the reported shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





747324101

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



OrbiMed Advisors LLC
Signature:/s/ Carl L. Gordon
Name/Title:Carl L. Gordon / Member
Date:11/16/2026
OrbiMed Capital LLC
Signature:/s/ Carl L. Gordon
Name/Title:Carl L. Gordon / Member
Date:11/16/2026

Keep reading